The Efficacy of Papaverine to Prevent Radial Artery Spasm During Transradial Cerebral Angiography
NCT05861765 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 240
Last updated 2023-06-12
Summary
Rationale:Papaverine is effective on radial artery spasm during transradial cerebral angiography.
Purpose: This multicenter, randomized, placebo-controlled, double blind, phase 2b trial aims to investigate the effect and safety of papaverine in treating radial artery spasm during transradial cerebral angiography.
Conditions
- Radial Artery Spasm
Interventions
- DRUG
-
Papaverine Hydrochloride
Slowly inject 10ml of papaverine hydrochloride solution (30mg/10ml) through the successfully implanted radial artery sheath, and continuously drip papaverine hydrochloride solution (60mg/500ml, 4ml/min) through the artery sheath during the operation. The compatible solutions are normal saline(0.9%);
- DRUG
-
normal saline
After inserting the radial artery sheath, slowly inject 10ml normal saline(0.9%) through the artery sheath, then continuously drip normal saline(0.9%, 500ml, 4ml/min) through the artery sheath during the operation.
Sponsors & Collaborators
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
lead OTHER
Principal Investigators
-
Yamei Tang, PhD · Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-24
- Primary Completion
- 2023-09-30
- Completion
- 2023-10-30
Countries
- China
Study Locations
More Related Trials
-
Effects of Tetrahydrobiopterin (BH4) on Leg Blood Flow and Exercise Capacity in Patients With Peripheral Artery Disease
NCT03493412 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of RIVAroxaban in Radial Artery Occlusion Treatment After Cardiac Catheterization
NCT06812455 ·Status: RECRUITING ·Phase: PHASE4
-
A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease
NCT00403494 ·Status: COMPLETED ·Phase: PHASE2
-
Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention
NCT01599078 ·Status: UNKNOWN ·Phase: NA
-
Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans
NCT04769206 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Low-dose Colchicine Inhibit Abdominal Aortic Aneurysm Growth Trial
NCT05361772 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects
NCT01349114 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD)
NCT01256775 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina
NCT02284048 ·Status: UNKNOWN ·Phase: PHASE4
-
Aliskiren Effect on Aortic Plaque Progression
NCT01417104 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
NCT05009862 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans
NCT02877173 ·Status: UNKNOWN ·Phase: PHASE2
-
Unacylated Ghrelin to Improve Functioning in PAD
NCT04377126 ·Status: COMPLETED ·Phase: PHASE2
-
Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?
NCT00457405 ·Status: COMPLETED ·Phase: PHASE4
-
Rivaroxaban 2.5 mg BID and Aspirin for Intermittent Claudication in PAD Patients
NCT04853719 ·Status: COMPLETED ·Phase: PHASE4
-
Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon
NCT02583789 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Ticagrelor China Pharmacokinetic/Pharmacodynamic Study
NCT02064985 ·Status: COMPLETED ·Phase: PHASE4
-
PF-00489791 For The Treatment Of Raynaud's
NCT01090492 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of Brachial Arterial t-PA Release, Endothelial Function, Obesity and Inflammation
NCT00780481 ·Status: TERMINATED ·Phase: NA
-
Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent Claudication
NCT00725881 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina
NCT02280850 ·Status: UNKNOWN ·Phase: PHASE4
-
Prostaglandin E1 in Outpatients With Intermittent Claudication
NCT01263925 ·Status: COMPLETED ·Phase: PHASE3
-
Possible Effects of Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy Volunteers
NCT04776499 ·Status: COMPLETED ·Phase: PHASE1
-
RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)
NCT02246660 ·Status: COMPLETED ·Phase: NA
-
SLOW-Slower Progress of caLcificatiOn With Vitamin K2
NCT04429035 ·Status: UNKNOWN ·Phase: NA